
IVD Reagents Dominated NMPA December 2025 Reports: 8 of 10 Cases Involving Roche and Ventana Products
In the review reports released in December 2025, eight out of ten pertained to IVD reagents, reflecting the continued advancement and regulatory scrutiny in fields








